Van Cutsem E, Shitara K, Deng W, Vaury A, et al. Gevokizumab, an interleukin-1beta (IL-1beta) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): "first-in-cancer" phase Ib study. Ann Oncol 2019;30 Suppl 4:iv77-iv78.
PMID: 32085292